Sihuan Pharmaceutical Holdings Group Ltd. (FRA:TEL1)

Market Cap	1.55B +122.9%
Revenue (ttm)	249.33M +19.6%
Net Income	-9.58M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	0.00 (0.85%)
Ex-Dividend Date	Sep 26, 2025

Volume	n/a
Average Volume	55
Open	0.1420
Previous Close	0.1370
Day's Range	0.1420 - 0.1420
52-Week Range	0.0605 - 0.2080
Beta	n/a
RSI	65.10
Earnings Date	Mar 27, 2026

About FRA:TEL1

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China and the United States. It operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthet...

• Industry: Pharmaceutical Preparations
• Founded: 2001
• Employees: 2,767
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TEL1

Financial Performance

In 2024, FRA:TEL1's revenue was 1.90 billion, an increase of 2.18% compared to the previous year's 1.86 billion. Losses were -216.66 million, 301.1% more than in 2023.

Financial numbers in CNY